Endothelin-1-receptor-mediated responses in resistance vessels of young and adult spontaneously hypertensive rats

J Hypertens. 2000 Jul;18(7):893-900. doi: 10.1097/00004872-200018070-00011.


Objective: To assess whether primary changes in endothelin-1 (ET-1) receptor responsiveness or secondary vessel functional modifications could characterize the effects evoked by ET-1 in the mesenteric vascular bed (MVB) of prehypertensive 5-week-old and 12-week-old spontaneously hypertensive rats (SHRs).

Design and methods: We used male 5-week-old and 12-week-old SHRs and sex- and age-matched Wistar-Kyoto (WKY) rats as controls. ET-1 receptor responsiveness was evaluated by ET-1 (0.04-2 micromol/l) concentration-response curves and repeated with indomethacin and BQ-123 (0.1-0.5 micromol/l), the latter a selective ETA receptor antagonist. ETB receptor responsiveness was tested by sarafotoxin S6c (1-100 nmol/l) and IRL-1620 (0.1-10 nmol/l) concentration-response curves, obtained in the noradrenaline-precontracted MVB.

Results: At 5 weeks of age, ET-1 induced a similar concentration-dependent contraction in SHRs and WKY rats, with an overlapping BQ-123 pA2 value (negative common logarithm of the antagonist that produces an agonist dose ratio of 2) in the two strains. Indomethacin was ineffective in both groups. Sarafotoxin S6c and IRL-1620 both evoked an ETB-mediated, significant relaxation, only in WKY rats. In 12-week-old SHRs, ET-1 evoked a markedly increased maximal effect compared with the response in WKY rats (P< 0.01); this was prevented by treatment with indomethacin. The BQ-123 pA2 value was higher in SHRs than in WKY rats (P< 0.01). Both sarafotoxin S6c and IRL-1620 evoked a significant concentration-dependent relaxation in WKY rats, which was not detected in SHR preparations.

Conclusions: Our results could suggest that the different responses evoked by ET-1 in the MVB of SHRs during the onset of hypertension may be related partially to primary alterations in the ET-1 receptorial pattern and partially to the onset of high blood pressure, leading to an impairment in the haemodynamic balance.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Antihypertensive Agents / pharmacology
  • Endothelin Receptor Antagonists
  • Endothelin-1 / pharmacology
  • Endothelins / pharmacology
  • Hypertension / metabolism
  • Hypertension / physiopathology*
  • Indomethacin / pharmacology
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiopathology
  • Norepinephrine / pharmacology
  • Peptide Fragments / pharmacology
  • Peptides, Cyclic / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptor, Endothelin A
  • Receptors, Endothelin / drug effects
  • Receptors, Endothelin / metabolism*
  • Vascular Resistance / drug effects*
  • Vascular Resistance / physiology
  • Vasoconstrictor Agents / pharmacology
  • Viper Venoms / pharmacology


  • Anti-Inflammatory Agents, Non-Steroidal
  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Endothelins
  • Peptide Fragments
  • Peptides, Cyclic
  • Receptor, Endothelin A
  • Receptors, Endothelin
  • Vasoconstrictor Agents
  • Viper Venoms
  • sarafotoxins s6
  • sovateltide
  • cyclo(Trp-Asp-Pro-Val-Leu)
  • Norepinephrine
  • Indomethacin